Advanced Search
Contact | Corporate | Help

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers

Sponsors:
  • GlaxoSmithKline
Phases:
  • Phase III
IndicationsAcronym:
  • Meningococcal Serogroups A, C, W, or Y Infections
Age Groups:
  • Child
Gender:
Both
Names:
  • Biological: Meningococcal vaccine GSK 134612
  • Biological: SynflorixTM
  • Biological: Tritanrix-HepB/HiberixTM
Enrollment:
750

Additional information about NCT01340898.


SourceSolution © 2008-2012